Compare Cisco Systems Inc (CSCO) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cisco Systems Inc vs GeneDx Holdings Corp — how do they compare? Cisco Systems Inc trades at $118.39 (market cap $452.96B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Cisco Systems Inc is far larger — about 224.2× GeneDx Holdings Corp's market cap, and Cisco Systems Inc pays a 1.46% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cisco Systems Inc for 86 Days and GeneDx Holdings Corp for 19 Days on average.
| CSCO | WGS | |
|---|---|---|
Market Cap | $452.96B | $2.02B |
Volume | 12,951,578 | 734,640 |
Sector | Technology | Health |
52-Week High | $130.00 | $167.51 |
52-Week Low | $67.46 | $34.51 |
Typical Hold Time | 86 Days | 19 Days |
Enterprise Value | $466.58B | $2.05B |
Dividend Yield | 1.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cisco Systems (CSCO) trades at $114.89, down 2.13% on the day, amid a bullish technical outlook supported by moving averages and strong institutional sentiment. The company reported robust Q2 2026 EPS of $1.22, beating estimates, with revenue growth driven by AI networking demand. Analysts maintain a 51.35% buy rating with a $129.77 consensus target, highlighting multi-year growth potential from AI infrastructure and Splunk integration.
The stock presents a favorable risk-reward profile with solid fundamentals, including a 20.95% net margin and consistent earnings beats. Key risks include competitive pressures in AI security and cyclical IT spending. Upside is supported by strong cash flow and strategic partnerships, though valuation multiples like a 34.5 P/E warrant monitoring amid macroeconomic uncertainties.
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cisco Systems Inc
Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
